LOS ANGELES, CA / ACCESSWIRE / September 28, 2017 / Lundin Law PC, a shareholder rights firm, announces a class action lawsuit against Acacia Communications, Inc. (“Acacia” or the “Company”) (NASDAQ: ACIA) for possible violations of federal securities laws from August 11, 2016 through July 13, 2017, inclusive (the “Class Period”). Investors, who purchased or otherwise acquired Acacia shares during the Class Period, should contact the firm prior to the October 13, 2017 lead plaintiff motion deadline.

To participate in this class action lawsuit, click here.

You can also call Brian Lundin, Esq., of Lundin Law PC, at 888-713-1033, or you can e-mail him at brian@lundinlawpc.com.

No class has been certified in the above action yet, and until a class is certified, you are not considered to be represented by an attorney. You may also choose to do nothing and be an absent class member.

According to the Complaint, during the Class Period, Acacia made materially false and/or misleading statements, and/or failed to disclose: that its manufacturing and quality control processes were deficient; that the foregoing deficiencies would likely disrupt the Company’s manufacturing and impact its revenues; and that as a result, Acacia’s public statements were materially false and misleading at all relevant times.

On May 31, 2017, Acacia disclosed that “the Company has identified a quality issue” affecting “a portion” of several thousand modules manufactured by one of Acacia’s three contract manufacturers, citing as the “root cause of this quality issue…a circuit board cleaning process that has since been eliminated.” On July 14, 2017, the Company issued a press release announcing that its preliminary financial and operating results for the quarter ended June 30, 2017. Acacia reported profit and revenue that missed estimates and revised its current-quarter guidance downward. The Company disclosed that its “second-quarter results were adversely affected by the quality issue identified at one of our three contract manufacturers that we announced on May 31.” When this information went public, shares of Acacia fell in value materially, which caused investors harm according to the Complaint.

Lundin Law PC was founded by Brian Lundin, Esq., a securities litigator based in Los Angeles dedicated to upholding shareholders’ rights.

This press release may be considered Attorney Advertising in certain jurisdictions under the applicable law and ethical rules.

Contact:

Lundin Law PC
Brian Lundin, Esq.
Telephone: 888-713-1033
Facsimile: 888-713-1125
brian@lundinlawpc.com
http://lundinlawpc.com/

SOURCE: Lundin Law PC

ReleaseID: 476616

LOS ANGELES, CA / ACCESSWIRE / September 28, 2017 / Lundin Law PC, a shareholder rights firm, announces a class action lawsuit against Forterra, Inc. (“Forterra” or the “Company”) (NASDAQ: FRTA) for possible violations of federal securities laws relating to its initial public offering (the “IPO”) on October 21, 2016. Investors, who purchased or otherwise acquired Forterra shares pursuant and/or traceable to the IPO, should contact the firm prior to October 13, 2017, the lead plaintiff motion deadline.

To participate in this class action lawsuit, click here.

You can also call Brian Lundin, Esq., of Lundin Law PC, at 888-713-1033, or e-mail him at brian@lundinlawpc.com.

No class has been certified in the above action yet, and until a class is certified, you are not considered represented by an attorney. You may also choose to do nothing and be an absent class member.

The Complaint alleges that the Registration Statement which Forterra used to conduct its IPO contained false and/or misleading statements, and/or failed to disclose material facts, specifically: that organic sales in the Company’s Drainage and Water segments significantly dropped; that Forterra was experiencing increased pricing pressure due to competition and continued softness in its concrete and steel pipe business; that the Company had been losing business in its important pipe and precast business, due in large part to operational problems at its production plants; and that Forterra had undisclosed material weaknesses in its internal controls that prevented it from accurately reporting and forecasting its financial results. Since the IPO, Forterra’s stock price has fallen about 75%, which caused investors harm according to the Complaint.

Lundin Law PC was founded by Brian Lundin, Esq., a securities litigator based in Los Angeles dedicated to upholding shareholders’ rights.

This press release may be considered Attorney Advertising in certain jurisdictions under the applicable law and ethics rules.

Contact:

Lundin Law PC
Brian Lundin, Esq.
Telephone: 888-713-1033
Facsimile: 888-713-1125
brian@lundinlawpc.com
http://lundinlawpc.com/

SOURCE: Lundin Law PC

ReleaseID: 476617

LOS ANGELES, CA / ACCESSWIRE / September 28, 2017 / Lundin Law PC, a shareholder rights firm, announces a class action lawsuit against Depomed, Inc. (“Depomed” or the “Company”) (NASDAQ: DEPO) for possible violations of federal securities laws from February 26, 2015 through August 7, 2017, inclusive (the “Class Period”). Investors, who purchased or otherwise acquired Depomed shares during the Class Period, should contact the firm prior to the October 17, 2017 lead plaintiff motion deadline.

To participate in this class action lawsuit, click here.

You can also call Brian Lundin, Esq., of Lundin Law PC, at 888-713-1033, or you can e-mail him at brian@lundinlawpc.com.

No class has been certified in the above action yet, and until a class is certified, you are not considered to be represented by an attorney. You may also choose to do nothing and be an absent class member.

According to the Complaint, during the Class Period, Depomed made false and/or misleading statements, and/or failed to disclose: that the Company engaged in questionable practices in connection with the sales and marketing of its opioid products; that this conduct would likely subject Depomed to heightened legal and regulatory scrutiny; and that as a result of the above, the Company’s public statements were materially false and misleading at all relevant times.

On August 7, 2017, Depomed revealed that it “recently received a request for information from the ranking minority member of the United States Senate Committee on Homeland Security and Governmental Affairs related to the promotion of opioids” and that Depomed had also received “subpoenas related to opioid sales and marketing from the Office of the Attorney General of Maryland and the United States Department of Justice.” When this information was released, Depomed’s stock price fell materially, which caused investors harm according to the Complaint.

Lundin Law PC was established by Brian Lundin, Esq., a securities litigator based in Los Angeles dedicated to upholding shareholders’ rights.

This press release may be considered Attorney Advertising in certain jurisdictions under the applicable law and rules of ethics.

Contact:

Lundin Law PC
Brian Lundin, Esq.
Telephone: 888-713-1033
Facsimile: 888-713-1125
brian@lundinlawpc.com
http://lundinlawpc.com/

SOURCE: Lundin Law PC

ReleaseID: 476618

NEW YORK, NY / ACCESSWIRE / September 28, 2017 / Newater Technology Inc. (NASDAQ: NEWA), a developer and manufacturer of membrane filtration products and related hardware and engineered systems that are used in the recycling, treatment, and discharge of wastewater, recently presented at the 2017 Disruptive Growth Company Showcase NYC at 1PM EDT/ 10AM PDT on September 27, 2017 at the Grand Hyatt 109 E 42nd St. Mr. Yuebiao Li, the Chairman and CEO presented and met with investors.

Each company was provided with a 30-minute time slot to present to an audience of investors and industry professionals. Company management was also available for one-on-one meetings with institutional investors.

For more information on the conference, please visit www.disruptnyc.com.

News Compliments of ACCESSWIRE.

About SeeThruEquity

Since its founding in 2011, SeeThruEquity has been committed to its core mission: providing impactful, high quality research on underfollowed smallcap and microcap equities. SeeThruEquity has pioneered an innovative business model for equity research that is not paid for and is unbiased. SeeThruEquity is the host of acclaimed investor conferences that are the ultimate event for publicly traded companies with market capitalizations less than $1 billion.

SeeThruEquity is approved to contribute its research reports and estimates to Thomson One Analytics (First Call), the leading estimates platform on Wall Street, as well as Capital IQ and FactSet. SeeThruEquity maintains one of the industry’s most extensive databases of opt-in institutional and high net worth investors. The firm is headquartered in Midtown Manhattan in New York City.

For more information, please visit www.seethruequity.com.

About Newater Technology, Inc.

Founded in 2012 and headquartered in Yantai, Shandong Province, Newater is a China-based wastewater purification treatment company that focuses on the development, manufacture and sale of disk tube reverse osmosis and disk tube nanofiltration membrane filtration products that are used in the recycling, treatment and discharge of wastewater. The Company’s products can be used across a wide spectrum of industries, including:

Leachate from landfills
Power plant wastewater
Wastewater from oil fields
Wastewater from gas production
High acid wastewater
Desalination

The Company also supplies hardware and engineered systems necessary to implement integrated solutions and provides related technical solutions in engineering support and installation, technical advice and other project related solutions.

For more information, please contact:

Tony Tian, CFA
Weitian Group LLC
Email: tony.tian@weitian-ir.com
Phone: +1-732-910-9692

SOURCE: Newater Technology Inc.

ReleaseID: 476612

NEW YORK, NY / ACCESSWIRE / September 28, 2017 / Capstone Turbine Corporation (www.capstoneturbine.com) (NASDAQ: CPST) the world’s leading clean technology manufacturer of microturbine energy systems, announced today that it will be featured as a presenting company at this year’s MicroCap Conference on October 5, 2017 in New York City.

Darren Jamison, Capstone’s President and Chief Executive Officer, will provide a corporate overview and growth strategy to investors at The MicroCap Conference on Thursday, October 5, 2017, at 2:00 pm Eastern Time.

“This is our first time presenting at The MicroCap Conference and we are excited to be an invited presenter. We look forward to this opportunity to discuss with the investment community our profitability plan including an update on Capstone Energy Finance and the potential impact to top line revenue as a result of the recent hurricanes,” said Mr. Jamison.

Darren Jamison and Jayme Brooks, Capstone’s Chief Financial Officer and Chief Accounting Officer, will be available for one-on-meetings throughout the conference day. Institutional investors interested in scheduling a one-on-one meeting with Capstone’s management team are encouraged to register for the conference (microcapconf.com/conferences/new-york-2-2017/). Once your registration is confirmed, you will be able to request a one-on-one meeting with Capstone.

CONFERENCE OVERVIEW AND STRUCTURE

The MicroCap Conference is an exclusive event for investors who specialize in small and microcap stocks. It is an opportunity to be introduced to and speak with management at some of the most attractive small companies, learn from various expert panels, and mingle with other microcap investors.

The MicroCap Conference will take place in New York City at the Essex House on October 5, 2017. Registration will begin on Thursday at 7:00AM, and will last until the evening. These days will be jam-packed with company sessions, presentations, good food, and plenty of time to network with other investors over drinks at the reception. This event does not allow service providers – only portfolio managers, analysts, and private investors.

REGISTRATION FOR INVESTORS

To register, please go to our website (microcapconf.com/conferences/new-york-2-2017/), and click “Investor Registration.”

PARTICIPATING COMPANIES

For our most updated list of companies, please go to our website (microcapconf.com/conferences/new-york-2-2017/).

MARQUEE SPONSORS

The Special Equities Group
Maxim Group

OTHER SPONSORS

M2 Compliance
MZ Group
Pryor Cashman
Wexler Burkhart Hirschberg & Unger
IRTH Communications
PCG Advisory Group
CORE IR
Catalyst IR
Marcum

News Compliments of ACCESSWIRE.

About Capstone Turbine Corporation

Capstone Turbine Corporation (www.capstoneturbine.com) (NASDAQ: CPST) is the world’s leading producer of low-emission microturbine systems and was the first to market commercially viable microturbine energy products. Capstone has shipped over 9,000 Capstone Microturbine systems to customers worldwide. These award-winning systems have logged millions of documented runtime operating hours. Capstone is a member of the U.S. Environmental Protection Agency’s Combined Heat and Power Partnership, which is committed to improving the efficiency of the nation’s energy infrastructure and reducing emissions of pollutants and greenhouse gases. A UL-Certified ISO 9001:2015 and ISO 14001:2015 certified company; Capstone is headquartered in the Los Angeles area with sales and/or service centers in the United States, Latin America, Europe, Middle East, and Asia.

“Capstone” and “Capstone Microturbine” are registered trademarks of Capstone Turbine Corporation. All other trademarks mentioned are the property of their respective owners.

FOR MORE INFORMATION

Please visit: www.microcapconf.com

Or, contact Tony Yu at tony@microcapconf.com.

SOURCE: Capstone Turbine Corporation

ReleaseID: 476609

IRVINE, CA / ACCESSWIRE / September 28, 2017 / Khang & Khang LLP (the “Firm”) announces a securities class action lawsuit against Dr. Reddy’s Laboratories Limited (“Dr. Reddy’s” or the “Company”) (NYSE: RDY). Investors, who purchased or otherwise acquired shares from June 17, 2015 through August 10, 2017, inclusive (the “Class Period”), are encouraged to contact the Firm before the October 24, 2017 lead plaintiff motion deadline.

If you purchased Dr. Reddy’s shares during the Class Period, please contact Joon M. Khang, Esq., of Khang & Khang LLP, 4000 Barranca Parkway, Suite 250, Irvine, CA 92604, by telephone at (949) 419-3834, or by e-mail at joon@khanglaw.com.

There has been no class certification in this case yet. Until certification occurs, you are not represented by an attorney. You may choose to take no action and remain a passive class member as well.

According to the Complaint, throughout the Class Period, Dr. Reddy’s made false and/or misleading statements, and/or failed to disclose, that it lacked an effective corporate quality system; and thus, its public statements were materially false and misleading at all relevant times. On August 10, 2017, the Company disclosed that the Regulatory of Germany (Regierung von Oberbayern) did not renew the good manufacturing practices compliance certificate of a formulations manufacturing unit of its German subsidiary Betapharm Arzneimittel, located in Hyderabad, India, following a recent inspection of the plant. When this news was announced, shares of Dr. Reddy’s lowered in value materially, which caused investors harm according to the Complaint.

If you wish to learn more about this lawsuit, or if you have any questions about this notice or your rights, please contact Joon M. Khang, Esq., a prominent litigator for nearly two decades, by telephone at (949) 419-3834, or by e-mail at joon@khanglaw.com.

This press release may constitute Attorney Advertising in certain jurisdictions.

Contact:

Joon M. Khang, Esq.
Telephone: 949-419-3834
Facsimile: 949-225-4474
joon@khanglaw.com

SOURCE: Khang & Khang LLP

ReleaseID: 476607

IRVINE, CA / ACCESSWIRE / September 28, 2017 / Khang & Khang LLP (the “Firm”) announces a securities class action lawsuit against Electronics for Imaging, Inc. (“Electronics for Imaging” or the “Company”) (NASDAQ: EFII). Investors, who purchased or otherwise acquired shares from February 22, 2017 through August 3, 2017, inclusive (the “Class Period”), are encouraged to contact the Firm before the October 10, 2017 lead plaintiff motion deadline.

If you purchased Electronics for Imaging shares during the Class Period, please contact Joon M. Khang, Esq., of Khang & Khang LLP, 4000 Barranca Parkway, Suite 250, Irvine, CA 92604, by telephone at (949) 419-3834, or by e-mail at joon@khanglaw.com.

There has been no class certification in this case yet, and until certification occurs, you are not represented by an attorney. You may choose to take no action and remain a passive class member as well.

According to the Complaint, during the Class Period, Electronics for Imaging made false and/or misleading statements, and/or failed to disclose: that the Company was improperly recognizing revenue; that the Company’s disclosure controls and procedures were ineffective; that the Company’s internal controls over financial reporting were ineffective; and thus, the Company’s public statements were materially false and misleading at all relevant times. On August 3, 2017, Electronics for Imaging notified investors that it was postponing a conference call in which it anticipated discussing second quarter 2017 preliminary results. The Company announced that its audit committee is conducting an independent review of the effectiveness of disclosure controls and internal controls over financial reporting. The problems identified by the audit committee include assessing timing of revenue recognition related to certain transactions, and therefore the Company may not be able to file its quarterly report on time. When this news went public, shares of Electronics for Imaging fell in value materially, which caused investors harm according to the Complaint.

If you wish to learn more about this lawsuit, or if you have questions about this notice or your rights, please contact Joon M. Khang, Esq., a prominent litigator for nearly two decades, by telephone at (949) 419-3834, or by e-mail at joon@khanglaw.com.

This press release may constitute Attorney Advertising in certain jurisdictions.

Contact:

Joon M. Khang, Esq.
Telephone: 949-419-3834
Facsimile: 949-225-4474
joon@khanglaw.com

SOURCE: Khang & Khang LLP

ReleaseID: 476601

IRVINE, CA / ACCESSWIRE / September 28, 2017 / Khang & Khang LLP (the “Firm”) announces a securities class action lawsuit against Sequans Communications S.A. (“Sequans” or the “Company”) (NYSE: SQNS). Investors who purchased or otherwise acquired Sequans shares from April 29, 2016 through July 31, 2017, inclusive (the “Class Period”), are encouraged to contact the Firm before the October 10, 2017 lead plaintiff motion deadline.

If you purchased Sequans shares during the Class Period, please contact Joon M. Khang, Esq., of Khang & Khang LLP, 4000 Barranca Parkway, Suite 250, Irvine, CA 92604, by telephone at (949) 419-3834, or by e-mail at joon@khanglaw.com.

There has been no class certification in this case yet, and until certification occurs, you are not represented by an attorney. You may choose to take no action and remain a passive class member as well.

The Complaint alleges that throughout the Class Period, Sequans made false and/or misleading statements, and/or failed to disclose, that it was improperly recognizing revenue, and as a result, its public statements were materially false and misleading at all relevant times. On August 1, 2017, the Company revealed that its revenue in the second quarter was negatively affected by a product return from an early 2016 sale related to the tablet business. Upon release of this information, Sequans’ stock price fell materially, which caused investors harm according to the Complaint.

If you wish to learn more about this lawsuit, or if you have questions concerning this notice or your rights, please contact Joon M. Khang, Esq., a prominent litigator for nearly two decades, by telephone at (949) 419-3834, or by e-mail at joon@khanglaw.com.

This press release may constitute Attorney Advertising in certain jurisdictions.

Contact

Joon M. Khang, Esq.
Telephone: 949-419-3834
Facsimile: 949-225-4474
joon@khanglaw.com

SOURCE: Khang & Khang LLP

ReleaseID: 476602

IRVINE, CA / ACCESSWIRE / September 28, 2017 / Khang & Khang LLP (the “Firm”) announces a securities class action lawsuit against TransDigm Group Incorporated (“TransDigm” or the “Company”) (NYSE: TDG). Investors, who purchased or otherwise acquired TransDigm shares from May 10, 2016 through January 19, 2017, inclusive (the “Class Period”), are encouraged to contact the Firm before October 10, 2017, the lead plaintiff motion deadline.

If you purchased TransDigm shares during the Class Period, please contact Joon M. Khang, Esq., of Khang & Khang LLP, 4000 Barranca Parkway, Suite 250, Irvine, CA 92604, by telephone at (949) 419-3834, or by e-mail at joon@khanglaw.com.

There has been no class certification in this case yet, and until certification occurs, you are not represented by an attorney. You may choose to take no action and remain a passive class member as well.

According to the Complaint, during the Class Period, TransDigm made false and/or misleading statements and/or failed to disclose: that the Company’s growth and profitability were artificially inflated as a result of its illicit business practices; that TransDigm used exclusive distributors to make noncompetitive government bids seems competitive; that the Company’s subsidiaries failed to list TransDigm as a parent entity when submitting government bids; and that as a result of the above, the Company’s statements about its business, operations, and prospects were false and misleading and/or lacked a reasonable basis. When this information was announced, shares of TransDigm dropped in value materially, which caused investors harm according to the lawsuit.

If you wish to learn more about this lawsuit, or if you have any questions about this notice or your rights, please contact Joon M. Khang, Esq., a prominent litigator for nearly two decades, by telephone at (949) 419-3834, or by e-mail at joon@khanglaw.com.

This press release may constitute Attorney Advertising in some jurisdictions.

Contact:

Joon M. Khang, Esq.
Telephone: 949-419-3834
Facsimile: 949-225-4474
joon@khanglaw.com

SOURCE: Khang & Khang LLP

ReleaseID: 476603